Pancreatic Cancer Research

ResearcherZhujiang HospitalActive in the last 2 years

Min Lu

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0009-0006-6415-203X; OpenAlex author ID A5100860358.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
1
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. USP11 stabilizes RALY to promote FXYD5-mediated aerobic glycolysis and aggravate pancreatic cancer progression. Last author DOI 10.1016/j.yexcr.2025.114758↗
  2. miR-1180 Targets FXYD5 to Regulate Pancreatic Cancer Cells Migration and Invasion. Co-author DOI 10.1007/s12033-023-00923-8↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Hongmin Xie · 2 shared papers, 2024–2025

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.